Johnson & Johnson reported a quarterly earnings increase of 5% year-over-year, with total revenue reaching $23.8 billion, driven by strong sales in its pharmaceutical segment.
AI Assistant
JOHNSON & JOHNSON
2025
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.